HIV resistance to lenacapavir weakens the virus's ability to replicate

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...
eLife

HIV-specific CD8+ T-cell proliferative response 24 weeks after early antiretroviral therapy initiation is associated with the subsequent reduction in the viral reservoir

In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ ...

Targeting key proteins in fight against ALS

Northwestern Medicine scientists have zeroed in on a cellular gatekeeper that may hold promise for treating abnormal protein ...
Science Daily

Scientists identify hidden protein interaction driving Parkinson’s disease

Researchers have identified a key molecular interaction that accelerates Parkinson’s disease by damaging the brain’s energy ...